{"id":"https://openalex.org/W3082358970","doi":null,"title":"Dapagliflozine can Induce and Maintain Type-2 Diabetes Remission","display_name":"Dapagliflozine can Induce and Maintain Type-2 Diabetes Remission","alternate_titles":[],"publication_year":2020,"publication_date":"2020-01-01","ids":{"openalex":"https://openalex.org/W3082358970","mag":"3082358970"},"language":"en","primary_location":{"id":"mag:3082358970","doi":null,"is_oa":true,"landing_page_url":"https://www.longdom.org/open-access/dapagliflozine-can-induce-and-maintain-type2-diabetes-remission.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4210201645","display_name":"Internal Medicine Open Access","issn_l":"2165-8048","issn":["2165-8048"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320466","host_organization_name":"OMICS Publishing Group","host_organization_lineage":["https://openalex.org/P4310320466"],"host_organization_lineage_names":["OMICS Publishing Group"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Internal Medicine Open Access","raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W3082358970"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.longdom.org/open-access/dapagliflozine-can-induce-and-maintain-type2-diabetes-remission.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073436174","display_name":"Mahmoud Younis","orcid":"https://orcid.org/0000-0001-9314-5572","observed_orcids":["https://orcid.org/0000-0001-9314-5572"]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Mahmoud Younis","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9314-5572","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5073436174"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"10","issue":"6","first_page":"1","last_page":"14"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dapagliflozin","display_name":"dapagliflozin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9139999747276306},{"id":"https://openalex.org/keywords/diabetes-remission","display_name":"diabetes remission","score":0.9789999723434448},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9980000257492065},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.8349999785423279},{"id":"https://openalex.org/keywords/glimepiride","display_name":"glimepiride","score":0.8569999933242798},{"id":"https://openalex.org/keywords/body-mass-index","display_name":"body mass index","score":0.8889999985694885},{"id":"https://openalex.org/keywords/renal-glucose-reabsorption","display_name":"renal glucose reabsorption","score":0.8529999852180481}],"concepts":[{"id":"https://openalex.org/C2777422806","wikidata":"https://www.wikidata.org/wiki/Q409898","display_name":"Dapagliflozin","level":4,"score":0.9924443960189819},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8158987760543823},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.7221702933311462},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.6686810255050659},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5543691515922546},{"id":"https://openalex.org/C2776307423","wikidata":"https://www.wikidata.org/wiki/Q425027","display_name":"Glimepiride","level":4,"score":0.5296663641929626},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5183197259902954},{"id":"https://openalex.org/C90466245","wikidata":"https://www.wikidata.org/wiki/Q7312490","display_name":"Renal glucose reabsorption","level":4,"score":0.4887423515319824},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.44015762209892273},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3956995904445648}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:3082358970","doi":null,"is_oa":true,"landing_page_url":"https://www.longdom.org/open-access/dapagliflozine-can-induce-and-maintain-type2-diabetes-remission.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4210201645","display_name":"Internal Medicine Open Access","issn_l":"2165-8048","issn":["2165-8048"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320466","host_organization_name":"OMICS Publishing Group","host_organization_lineage":["https://openalex.org/P4310320466"],"host_organization_lineage_names":["OMICS Publishing Group"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Internal Medicine Open Access","raw_type":null}],"best_oa_location":{"id":"mag:3082358970","doi":null,"is_oa":true,"landing_page_url":"https://www.longdom.org/open-access/dapagliflozine-can-induce-and-maintain-type2-diabetes-remission.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4210201645","display_name":"Internal Medicine Open Access","issn_l":"2165-8048","issn":["2165-8048"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320466","host_organization_name":"OMICS Publishing Group","host_organization_lineage":["https://openalex.org/P4310320466"],"host_organization_lineage_names":["OMICS Publishing Group"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Internal Medicine Open Access","raw_type":null},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W1022684664","https://openalex.org/W1546723301","https://openalex.org/W1925067399","https://openalex.org/W1970727299","https://openalex.org/W1975588287","https://openalex.org/W2022419155","https://openalex.org/W2025447674","https://openalex.org/W2032777249","https://openalex.org/W2051587831","https://openalex.org/W2090556647","https://openalex.org/W2138592519","https://openalex.org/W2731777658","https://openalex.org/W2766597988","https://openalex.org/W2767062006","https://openalex.org/W2907933743","https://openalex.org/W3198570063"],"related_works":["https://openalex.org/W4229374010","https://openalex.org/W4408056455","https://openalex.org/W7132593803","https://openalex.org/W2146926016","https://openalex.org/W7064769498","https://openalex.org/W4406714386","https://openalex.org/W4389966083","https://openalex.org/W2021524336","https://openalex.org/W3116143","https://openalex.org/W2150855258"],"abstract_inverted_index":{"Introduction:":[0],"Type":[1],"2":[2,72,85,91,154,180],"diabetes":[3,73,86,155,181],"mellitus,":[4],"has":[5],"gained":[6],"a":[7,50,96,124,137,168],"lot":[8],"of":[9,16,52,100,121,150,158],"attention":[10],"in":[11,23,62,114,128,141,143],"recent":[12],"years":[13],"as":[14],"one":[15,157],"the":[17,24,43,63,129,144,159],"most":[18,160],"important":[19],"chronic":[20,35],"progressive":[21],"diseases":[22],"world,":[25],"which":[26,32,37],"slowly":[27],"crawls":[28],"towards":[29],"longevity":[30],"and":[31,42,81,105,111],"involves":[33],"many":[34],"complications,":[36],"are":[38],"dangerous":[39],"to":[40,166,173,178],"health":[41],"economy.":[44],"Sodium-glucose":[45],"cotransporter-2":[46],"(SGLT2)":[47,67],"inhibitors":[48,68],"represent":[49],"category":[51],"newly":[53],"discovered":[54],"drugs":[55],"that":[56,170],"work":[57],"by":[58],"preventing":[59],"glucose":[60],"reabsorption":[61],"proximal":[64],"renal":[65],"tubules.":[66],"may":[69],"induce":[70],"type":[71,84,153,179],"remission.":[74,174],"Design:":[75],"Randomized,":[76],"-controlled":[77],"trial,":[78],"6-month":[79],"trial.\r\n\r\nMaterials":[80],"Methods:":[82],"100":[83],"patients":[87],"were":[88],"randomized":[89],"into":[90],"groups.\r\n\r\nResults:":[92],"The":[93,133],"results":[94,134],"show":[95,136],"statistically":[97,138],"significant":[98,112,126,139],"decrease":[99,140],"A1C":[101,115],"levels":[102,116],"after":[103,117,147],"3":[104,118,131],"6":[106,148],"months":[107,119,149],"treatment":[108,120],"with":[109],"dapagliflozin":[110,145],"change":[113,127],"glimepiride":[122],"but":[123],"no":[125],"next":[130],"months.":[132],"also":[135],"BMI":[142],"group":[146],"treatment.\r\n\r\nConclusion:":[151],"As":[152],"is":[156,164],"disabling":[161],"diseases,":[162],"it":[163],"necessary":[165],"find":[167],"drug":[169],"can":[171,176],"lead":[172,177],"Dapagliflozin":[175],"remission":[182]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3082358970","counts_by_year":[],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2020-09-08T00:00:00"}
